To evaluate the relevance of these findings to cancer, we investigated the p53-mutant breast cancer cell line models MDA-MB-231 and BT549, both of which represent the ‘triple-negative’ subtype of breast cancer. This evidence concerns the gene TP53 and breast carcinoma.